In ovarian cancer and hepatocellular carcinoma, high HDAC6 is associated with advanced clinical stage, higher number of tumours, vascular and intrahepatic invasion, and metastasis, which are related to poor prognosis, respectively [31]. This evidence concerns the gene HDAC6 and hepatocellular carcinoma.